BASF starts trial production of mononitrobenzene in Chongqing, first precursor plant of integrated MDI complex
- Mononitrobenzene plant is one part of RMB 8 billion (approx. €860 million) BASF investment
- MDI production will support key industries in China’s western areas
April 29, 2015 – Chongqing, China – BASF has begun trial operations at the mononitrobenzene plant within the integrated 400,000 metric ton methylene diphenyl diisocyanate (MDI) complex in Chongqing, China. Mononitrobenzene is a precursor for the production of MDI.
This MDI site covers an area of more than 50 hectares, including facilities of 400,000 metric tons per year of Mononitrobenzene, 300,000 metric tons per year of aniline, 400,000 metric tons per year of crude MDI, and an MDI splitter with a capacity of 400,000 metric tons per year.
MDI is an important component for polyurethanes – an extremely versatile plastics material that contributes towards improved insulation for appliances and reefer containers, provides lighter and more modern materials for cars, and helps save energy in buildings.
About BASF
At BASF, we create chemistry – and have been doing so for 150 years. Our portfolio ranges from chemicals, plastics, performance products and crop protection products to oil and gas. As the world’s leading chemical company, we combine economic success with environmental protection and social responsibility. Through science and innovation, we enable our customers in nearly every industry to meet the current and future needs of society. Our products and solutions contribute to conserving resources, ensuring nutrition and improving quality of life. We have summed up this contribution in our corporate purpose: We create chemistry for a sustainable future. BASF had sales of over €74 billion in 2014 and around 113,000 employees as of the end of the year. BASF shares are traded on the stock exchanges in Frankfurt (BAS), London (BFA) and Zurich (AN). Further information on BASF is available on the Internet at www.basf.com.
P-15-218
